- Home
- IMUX vs IROQ Comparison
IMUX vs IROQ Comparison
Compare IMUX & IROQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- IROQ
- Stock Information
- Founded
- IMUX 2016
- IROQ 1883
- Country
- IMUX United States
- IROQ United States
- Employees
- IMUX N/A
- IROQ N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- IROQ Savings Institutions
- Sector
- IMUX Health Care
- IROQ Finance
- Exchange
- IMUX Nasdaq
- IROQ Nasdaq
- Market Cap
- IMUX 67.1M
- IROQ 79.7M
- IPO Year
- IMUX N/A
- IROQ 2011
- Fundamental
- Price
- IMUX $0.72
- IROQ $24.70
- Analyst Decision
- IMUX Strong Buy
- IROQ
- Analyst Count
- IMUX 6
- IROQ 0
- Target Price
- IMUX $11.60
- IROQ N/A
- AVG Volume (30 Days)
- IMUX 2.4M
- IROQ 1.6K
- Earning Date
- IMUX 08-07-2025
- IROQ 04-29-2025
- Dividend Yield
- IMUX N/A
- IROQ 1.60%
- EPS Growth
- IMUX N/A
- IROQ 69.23
- EPS
- IMUX N/A
- IROQ 1.05
- Revenue
- IMUX N/A
- IROQ $25,099,000.00
- Revenue This Year
- IMUX N/A
- IROQ N/A
- Revenue Next Year
- IMUX N/A
- IROQ N/A
- P/E Ratio
- IMUX N/A
- IROQ $23.85
- Revenue Growth
- IMUX N/A
- IROQ 12.02
- 52 Week Low
- IMUX $0.56
- IROQ $14.85
- 52 Week High
- IMUX $2.11
- IROQ $25.76
- Technical
- Relative Strength Index (RSI)
- IMUX 36.47
- IROQ 53.16
- Support Level
- IMUX $0.71
- IROQ $24.37
- Resistance Level
- IMUX $0.91
- IROQ $24.96
- Average True Range (ATR)
- IMUX 0.07
- IROQ 0.24
- MACD
- IMUX 0.00
- IROQ 0.05
- Stochastic Oscillator
- IMUX 29.20
- IROQ 61.83
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About IROQ IF Bancorp Inc.
IF Bancorp Inc is a holding company. It is mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company with the association take deposits from the general public and invest those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, others and also a variety of deposit accounts and alternative delivery channels.